Takeda-BIRAC Alliance Deepens Big Pharma Support For Biotech Start-ups In India

Proposed National Pharmaceutical Policy To Further Agenda

Takeda’s alliance with BIRAC marks a deepening of big pharma’s support for India’s budding biotech innovation ecosystem. Takeda brings strengths in rare diseases and immunology to a table shared by others like Pfizer and Novartis. Meanwhile, the proposed National Pharmaceutical Policy is seen furthering innovation via public-private partnerships

Innovation concept
India Aims To Dial Up Innovation Via Collaboration With Big Pharma • Source: Shutterstock

Takeda Pharmaceutical Co. Ltd. recently announced a three-year agreement with India's Biotechnology Industry Research Assistance Council (BIRAC) to advise and mentor biotech innovators on the journey from ideation to commercialization and deployment of healthcare solutions.

A not-for-profit public sector enterprise set up by the Department of Biotechnology, BIRAC acts as an interface in supporting biotech startups for research and

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Scrip